Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor and NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05277051
What this trial is testing

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 152
Early research (Phase 1)Looking for participantsNCT06839105
What this trial is testing

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

Who this might be right for
Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
Shanghai Junshi Bioscience Co., Ltd. 214
Testing effectiveness (Phase 2)Looking for participantsNCT05431270
What this trial is testing

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Who this might be right for
Non Small Cell Lung CancerPancreatic Ductal Adenocarcinoma
Phanes Therapeutics 40
Early research (Phase 1)Not Yet RecruitingNCT07807956
What this trial is testing

Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+6 more
AbbVie 130
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT00413283
What this trial is testing

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerChemotherapy-Induced ThrombocytopeniaNon-Small Cell Lung Cancer+5 more
Amgen 63
Early research (Phase 1)UnknownNCT04556669
What this trial is testing

Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultCervical CancerSarcoma+1 more
Hebei Senlang Biotechnology Inc., Ltd. 30
Early research (Phase 1)Ended earlyNCT00565227
What this trial is testing

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Who this might be right for
Non-Small-Cell Lung CarcinomaProstate CancerBladder Cancer+1 more
University of Michigan Rogel Cancer Center 12
Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center
Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Testing effectiveness (Phase 2)Looking for participantsNCT07169734
What this trial is testing

Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Who this might be right for
Cervical Squamous Cell CarcinomaSquamous Non-small-cell Lung CancerColorectal Cancer+2 more
Alentis Therapeutics AG 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT04180371
What this trial is testing

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Who this might be right for
Advanced Solid Tumor Historically Known for High EphA2 ExpressionUrothelial CancerOvarian Cancer+4 more
BicycleTx Limited 288
Testing effectiveness (Phase 2)Study completedNCT01628471
What this trial is testing

MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Uman Pharma 20
Early research (Phase 1)Ended earlyNCT05480865
What this trial is testing

SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorMetastatic NSCLC+1 more
Navire Pharma Inc., a BridgeBio company 28
Testing effectiveness (Phase 2)Study completedNCT01204099
What this trial is testing

Study of PX-866 and Docetaxel in Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Cascadian Therapeutics Inc. 223
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Testing effectiveness (Phase 2)Looking for participantsNCT06239194
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Who this might be right for
Biliary Tract CancerBreast CancerCervical Cancer+13 more
ModeX Therapeutics, An OPKO Health Company 285
Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Next Page